New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
08:35 EDTAUXLAuxilium risk/reward remains favorable, says UBS
UBS continues to views Auxilium risk/reward favorable based on its growing business and potential for further indications for Xiaflex and business development. Shares are Buy rated with a $52 price target, up from $50.
News For AUXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 18, 2015
07:12 EDTAUXLInnocoll appoints James Tursi, M.D., as Chief Medical Officer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use